Dow Up0.64% Nasdaq Up0.68%

Allergan Inc. (AGN)

-NYSE
169.97 0.07(0.04%) Sep 18, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,864,200   1,646,100   1,684,400   1,558,700  
Cost of Revenue222,200  204,500  204,600  192,200  
Gross Profit 1,642,000   1,441,600   1,479,800   1,366,500  
Operating Expenses
Research Development288,700  349,000  269,400  257,600  
Selling General and Administrative718,900  658,600  715,400  589,300  
Non Recurring(1,500)24,300  12,000  600  
Others28,000  27,800  28,200  28,800  
Total Operating Expenses1,034,100  1,059,700  1,025,000  876,300  
Operating Income or Loss 607,900   381,900   454,800   490,200  
Income from Continuing Operations
Total Other Income/Expenses Net(13,800)(4,600)4,400  (14,000)
Earnings Before Interest And Taxes594,100  377,300  459,200  476,200  
Interest Expense19,700  15,700  18,200  19,400  
Income Before Tax574,400  361,600  441,000  456,800  
Income Tax Expense156,000  103,100  128,400  123,900  
Minority Interest(1,200)(600)600  (1,000)
Net Income From Continuing Ops418,400  258,500  312,600  332,900  
Non-recurring Events
Discontinued Operations -  (600)(300)(32,100)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 417,200   257,300   312,900   299,800  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 417,200   257,300   312,900   299,800  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.